Juliet Goodchild


Juliet is the inventor of the Phaxan® technology, and co‐founder of Drawbridge. She has been a key person in the research and development of Phaxan® from the early concept to late stage clinical development.  Juliet is a medical graduate and specialist in anaesthesia & pain medicine having a diploma from the Royal College of Anaesthetists in London, UK.  She has a broad range of medical practice experience, having practised anaesthesia and Pain Medicine for 25 years in three continents (India, Europe and Australia).  Juliet also has a PhD in neuroscience (Pain Medicine) from the University of Leeds.

Juliet is an author of several scientific papers published in major international peer reviewed journals in the fields of anaesthesia and pain medicine under her professional surname Dr Serrao.

Click for LinkedIn at:

Colin Goodchild


colin-goodchildColin is a co‐founder of Drawbridge and serves as Chief Medical Officer. He is a UK medical graduate from Cambridge University with a PhD in neuroscience from the University of Leeds. He is a specialist in anaesthesia & pain medicine and holds post graduate diplomas from the Royal College of Anaesthetists in London, UK and also from the Australia & NZ College of Anaesthetists and its Faculty of Pain Medicine. He has published in excess of 100 publications in major international journals in his field.

Colin is very active clinically in providing anaesthesia for surgery and as a tertiary referral Pain Medicine Specialist. He is well known as an inventor in anaesthesia and analgesia being listed inventor on 17 patents which have been licensed for development and commercialisation to various companies including: Purdue Frederick; Vernalis; Balboa Biosciences; and CNSBio.  He has held the positions of Director and CSO at CNSBio Pty Ltd. Colin is recognised as a leader in translational medicine, combining knowledge and skills as a neuroscientist, clinician, practising anaesthetist and entrepreneur.

Click for Researchgate profile